Trading Day Review: CureVac N.V. (CVAC)’s financial ratios: A comprehensive overview

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.79 million shares were traded. CVAC stock price reached its highest trading level at $2.49 during the session, while it also had its lowest trading level at $2.36.

Ratios:

We take a closer look at CVAC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.56. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, SVB Securities on June 08, 2023, initiated with a Outperform rating and assigned the stock a target price of $13.

On January 19, 2023, UBS Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $8 to $18.

Jefferies Upgraded its Hold to Buy on January 09, 2023, whereas the target price for the stock was revised from $9 to $21.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVAC now has a Market Capitalization of 546374592 and an Enterprise Value of 124342848. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.94 while its Price-to-Book (P/B) ratio in mrq is 0.86. Its current Enterprise Value per Revenue stands at 2.9 whereas that against EBITDA is -0.514.

Stock Price History:

The Beta on a monthly basis for CVAC is 2.50, which has changed by -0.6822916 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, CVAC has reached a high of $12.36, while it has fallen to a 52-week low of $2.44. The 50-Day Moving Average of the stock is -23.49%, while the 200-Day Moving Average is calculated to be -57.25%.

Shares Statistics:

According to the various share statistics, CVAC traded on average about 784.05K shares per day over the past 3-months and 648410 shares per day over the past 10 days. A total of 223.88M shares are outstanding, with a floating share count of 91.60M. Insiders hold about 59.08% of the company’s shares, while institutions hold 10.02% stake in the company. Shares short for CVAC as of 1711584000 were 5014975 with a Short Ratio of 6.40, compared to 1709164800 on 4394009. Therefore, it implies a Short% of Shares Outstanding of 5014975 and a Short% of Float of 12.620000000000001.

Earnings Estimates

The market rating for CureVac N.V. (CVAC) is a result of the insights provided by 6 analysts actively involved in the assessment.On average, analysts expect EPS of -$0.2 for the current quarter, with a high estimate of -$0.11 and a low estimate of -$0.33, while EPS last year was -$0.66. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.15 and low estimates of -$0.23.

Analysts are recommending an EPS of between -$0.89 and -$1.18 for the fiscal current year, implying an average EPS of -$1.02. EPS for the following year is -$0.97, with 9 analysts recommending between -$0.53 and -$1.4.

Revenue Estimates

According to 7 analysts, the current quarter’s revenue is expected to be $36M. It ranges from a high estimate of $76.82M to a low estimate of $20.05M. As of the current estimate, CureVac N.V.’s year-ago sales were $12.83M, an estimated increase of 180.60% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $16.01M, an increase of 10.70% less than the figure of $180.60% in the same quarter last year. There is a high estimate of $25.61M for the next quarter, whereas the lowest estimate is $8.56M.

A total of 10 analysts have provided revenue estimates for CVAC’s current fiscal year. The highest revenue estimate was $109.89M, while the lowest revenue estimate was -$-, resulting in an average revenue estimate of $59.15M. In the same quarter a year ago, actual revenue was $73.92M, down -20.00% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $75.22M in the next fiscal year. The high estimate is $173.9M and the low estimate is -$-. The average revenue growth estimate for next year is up 27.20% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]